New Key Statistics Module, Z-Score and F-Score
SZSE:002693 Key Ratios
Market Cap ¥ M | 6,635.01 |
Enterprise Value ¥ M | 6,822.27 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 15.34 |
Price/Sales | 37.73 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 180.00 |
EPS (TTM) ¥ | -0.21 |
Beneish M-Score | -3.11 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -69.59 |
EV-to-EBITDA | -69.59 |
PEG | -- |
Shares Outstanding M | 414.69 |
Net Margin (%) | -48.14 |
Operating Margin % | -29.48 |
Pre-tax Margin (%) | -59.19 |
Quick Ratio | 0.49 |
Current Ratio | 1.00 |
ROA % (ttm) | -10.59 |
ROE % (ttm) | -18.51 |
ROIC % (ttm) | -7.07 |
Dividend Yield % | -- |
Altman Z-Score | 9.73 |
SZSE:002693 Number of Guru Trades
SZSE:002693 Volume of Guru Trades
Gurus Latest Trades with SZSE:002693
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002693 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hainan Shuangcheng Pharmaceuticals Co Ltd Insider Transactions
No Available Data